"

According to the latest report published by Data Bridge Market Research, the Next Generation Sequencing (NGS) Market

 CAGR Value 

• The global next generation sequencing (NGS) market was valued at USD 15.98 billion in 2024 and is expected to reach USD 49.21 billion by 2032
• During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 15.10%, primarily driven by continuous advancements in sequencing technologies and increasing clinical applications

This world-wide Next Generation Sequencing (NGS) Market report is generated by a team of multilingual researchers who are skilled at different languages and hence perform market research internationally. With this report, businesses can get clear idea about how the market is going to perform in the forecast years with understandable details about market definition, classifications, applications, and engagements. A genius team along with project managers serve the clients on every strategic aspect including product development, key areas of development, application modelling, use of technologies, the acquisition strategies, exploring niche growth opportunities and new markets.

Stay informed with our latest keyword market research covering strategies, innovations, and forecasts. Download full report: https://www.databridgemarketresearch.com/reports/global-next-generation-sequencing-ngs-market

Next Generation Sequencing (NGS) Market Segmentation and Market Companies

Segments

- On the basis of product & service, the global next-generation sequencing (NGS) market can be segmented into pre-sequencing products & services, NGS platforms, consumables, services for platforms, sequencing services, data analysis, storage & management, and other NGS products & services.
- Based on technology, the market can be categorized into sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, nanopore sequencing, and other sequencing technologies.
- In terms of application, the NGS market can be divided into diagnostics, drug discovery, precision medicine, and agriculture & animal research.
- By end-user, the market can be split into academic & research institutes, pharmaceutical & biotechnology companies, hospitals & clinics, and other end-users.

Market Players

- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Oxford Nanopore Technologies
- Qiagen N.V.
- BGI Genomics
- PerkinElmer Inc.
- Agilent Technologies, Inc.
- F. Hoffmann-La Roche AG
- Pacific Biosciences of California, Inc.
- 10x Genomics

The global Next Generation Sequencing (NGS) market is witnessing significant growth due to factors such as increased applications in clinical diagnostics and drug discovery, technological advancements, declining costs of sequencing, and the growing need for personalized medicine. The market is highly competitive, with key players focusing on strategic initiatives such as mergers and acquisitions, partnerships, and new product launches to strengthen their market presence.

The product & service segment holds a significant market share, driven by the rising demand for consumables, sequencing platforms, and data analysis services. The sequencing by synthesis technology dominates the market, owing to its high accuracy and throughput. In terms of applications, the diagnostics segment is experiencing rapid growth due to the increasing adoption of NGS in cancer profiling and genetic disease detection. The pharmaceutical & biotechnology companies segment is the largest end-user of NGS, as they utilize sequencing technology for drug development and research purposes.

Illumina, Inc. is a key player in the NGS market, known for its innovative sequencing platforms and comprehensive product portfolio. Thermo Fisher Scientific Inc. is another major player, offering a wide range of NGS products and services. Oxford Nanopore Technologies is gaining traction with its nanopore sequencing technology, known for its portability and real-time data analysis capabilities. Qiagen N.V. is a prominent player in the NGS data analysis and storage segment, providing solutions for NGS data management. BGI Genomics, with its focus on genome sequencing and diagnostics, is also a significant player in the market.

Overall, the global NGS market is poised for substantial growth, driven by ongoing advancements in sequencing technologies, increasing research activities in genomics, and the expanding applications of NGS across various sectors.

The global next-generation sequencing (NGS) market is expected to witness robust growth in the coming years, propelled by several key factors. One significant driver is the rising adoption of NGS in clinical diagnostics, particularly in cancer profiling and genetic disease detection. The ability of NGS technology to provide precise and comprehensive genetic information is revolutionizing disease diagnosis and treatment, driving its uptake in healthcare settings. Additionally, the use of NGS in drug discovery is also contributing to market growth, as pharmaceutical and biotechnology companies leverage sequencing data to develop targeted therapies and personalized medicine solutions.

Technological advancements in NGS platforms and consumables are further fueling market expansion. Companies like Illumina, Inc. and Thermo Fisher Scientific Inc. are at the forefront of innovation in sequencing technologies, continuously improving the speed, accuracy, and cost-efficiency of NGS processes. The development of novel sequencing technologies, such as nanopore sequencing by Oxford Nanopore Technologies, is opening up new possibilities in real-time data analysis and portable sequencing solutions. These advancements are driving increased adoption of NGS across a wide range of applications, from agriculture and animal research to precision medicine.

The competitive landscape of the global NGS market is characterized by intense rivalry among key players vying for market share. Companies like Qiagen N.V. and BGI Genomics are focusing on data analysis and genome sequencing, respectively, to address the growing demand for robust bioinformatics solutions and diagnostic services. Strategic initiatives such as mergers, acquisitions, and partnerships are common among market players as they seek to enhance their product portfolios, expand their geographic presence, and strengthen their competitive positions.

Looking ahead, the global NGS market is poised for continued growth as research activities in genomics and genetics expand, creating new opportunities for NGS applications. The increasing demand for personalized medicine solutions, coupled with the declining costs of sequencing, is expected to drive further adoption of NGS across diverse sectors. As technological innovations continue to shape the NGS landscape, market players will need to stay agile and proactive in responding to evolving customer needs and industry trends to capitalize on the promising opportunities that lie ahead.The global next-generation sequencing (NGS) market is undergoing a transformative phase driven by a myriad of factors shaping the industry landscape. With the rising demand for personalized medicine solutions, the healthcare sector is increasingly adopting NGS technology for precise diagnostics and efficient treatment strategies. The diagnostic segment, particularly in cancer profiling and genetic disease detection, is witnessing substantial growth as NGS offers comprehensive genetic information crucial for accurate diagnosis and targeted therapies. Furthermore, the use of NGS in drug discovery by pharmaceutical and biotechnology companies is propelling market growth, enabling researchers to develop tailored therapies and precision medicine solutions.

Advancements in NGS technologies by key industry players such as Illumina, Inc., Thermo Fisher Scientific Inc., and Oxford Nanopore Technologies are instrumental in driving market expansion. These companies are continuously enhancing the speed, accuracy, and cost-efficiency of NGS processes, thereby widening the scope of applications across various sectors like agriculture, animal research, and precision medicine. The introduction of novel sequencing technologies such as nanopore sequencing is revolutionizing real-time data analysis and portability, offering new avenues for NGS adoption and innovation.

The competitive landscape of the NGS market is characterized by intense rivalry among market players striving to enhance their market presence and product portfolios. Companies like Qiagen N.V. and BGI Genomics are focusing on data analysis and genome sequencing, respectively, to cater to the increasing demand for bioinformatics solutions and diagnostic services. Strategic collaborations, mergers, and acquisitions are common strategies employed by industry players to expand their market reach, leverage complementary capabilities, and strengthen their competitive standing in the dynamic NGS market.

Looking ahead, the global NGS market is poised for sustained growth fueled by burgeoning research activities in genomics and genetics. The growing emphasis on personalized medicine solutions and the decreasing costs of sequencing are projected to further propel NGS adoption across diverse sectors. As technological innovations continue to drive industry evolution, market players need to remain agile and responsive to changing customer needs and market dynamics to capitalize on the abundant opportunities present in the dynamic NGS landscape.

Frequently Asked Questions About This Report

Is the Next Generation Sequencing (NGS) Market currently in the growth or maturity stage?
How is Social Responsibility impacting the Next Generation Sequencing (NGS) Market share?
How will Quantum Computing disrupt the Next Generation Sequencing (NGS) Market by 2033?
How does the Premiumization trend affect Next Generation Sequencing (NGS) Market consumer choices?
How does the Next Generation Sequencing (NGS) Market in Europe address data privacy concerns?
What are the bottlenecks in the Next Generation Sequencing (NGS) Market supply chain?
What is the lifetime value (LTV) of a Next Generation Sequencing (NGS) Market customer?
What is the estimated market valuation for Next Generation Sequencing (NGS) Market in 2026?
How much will the Next Generation Sequencing (NGS) Market valuation grow if AI adoption doubles?
What is the PESTLE analysis for the global Next Generation Sequencing (NGS) Market industry?
What is the expected exit strategy for Next Generation Sequencing (NGS) Market start-ups?
What is the margin structure across the Next Generation Sequencing (NGS) Market value chain?
What is the valuation of Next Generation Sequencing (NGS) Market in the Renewable Energy market?

Browse More Reports:

Global Online Entertainment Market
Global Pharmaceutical Logistics Market
Global Holographic Market
Global Orthodontic Supplies Market
Global Polymerase Chain Reaction (PCR) Devices Market
LATAM RFID Tags Market
North America Olive Oil Market
Europe Lithium Ion Battery Market
Global Semiconductor IP Market
Europe Edible Insects Market
U.S. Social Determinants of Health (SDOH) Market
Europe Digital Lending Platform Market
Global Poultry Feed Market
Global Wearable Electrocardiogram (ECG) Monitors Market
Global Potassium Chloride Market
Global Hyperlipidemia Market
Middle East and Africa Teleradiology Market
Europe Edible Oil Market
Global Electric Enclosure Market
Global Phosphate Fertilizers Market
Global Fabric Softener and Conditioners Market
South America Agriculture Drone Market
Global Bonsai Market
Global Cloud Kitchen Market
Global Distributed Fiber Optic Sensor Market

Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 986
Email:- [email protected]"